You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR VINORELBINE TARTRATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VINORELBINE TARTRATE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002813 ↗	Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer	Completed	National Cancer Institute (NCI)	Phase 2	1997-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.
NCT00002813 ↗	Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer	Completed	Gynecologic Oncology Group	Phase 2	1997-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.
NCT00002823 ↗	Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer	Completed	Gustave Roussy, Cancer Campus, Grand Paris	Phase 3	1995-02-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VINORELBINE TARTRATE

Condition Name

Chart
Table

Condition Name for VINORELBINE TARTRATE
Intervention	Trials
Lung Cancer	22
Breast Cancer	11
Prostate Cancer	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VINORELBINE TARTRATE
Intervention	Trials
Lung Neoplasms	28
Carcinoma, Non-Small-Cell Lung	27
Breast Neoplasms	21
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VINORELBINE TARTRATE

Trials by Country

Map
Table

Trials by Country for VINORELBINE TARTRATE
Location	Trials
United States	570
Canada	51
Australia	18
United Kingdom	18
Italy	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VINORELBINE TARTRATE
Location	Trials
California	24
Illinois	22
New York	22
Florida	18
Texas	18
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VINORELBINE TARTRATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VINORELBINE TARTRATE
Clinical Trial Phase	Trials
Phase 3	22
Phase 2/Phase 3	2
Phase 2	41
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VINORELBINE TARTRATE
Clinical Trial Phase	Trials
Completed	46
Unknown status	15
Terminated	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VINORELBINE TARTRATE

Sponsor Name

Chart
Table

Sponsor Name for VINORELBINE TARTRATE
Sponsor	Trials
National Cancer Institute (NCI)	34
Children's Oncology Group	6
Alliance for Clinical Trials in Oncology	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VINORELBINE TARTRATE
Sponsor	Trials
Other	84
NIH	35
Industry	21
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.